Citrine Global Corp.

Equities

CTGL

US17737V1052

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 03:11:46 2024-04-15 pm EDT			5-day change	1st Jan Change
0.0125 ^USD	+4.17%		0.00%	-37.50%

Feb. 23	Citrine Global Corp. Announces Resignation of Mr. Doron Birger from the Board	CI
Feb. 09	Citrine Global Corp. announced that it has received $0.055 million in funding	CI

Citrine Global Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022

May 16, 2022 at 03:46 pm EDT

Citrine Global Corp. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was USD 0.729 million compared to USD 2.1 million a year ago.

Latest news about Citrine Global Corp.

Citrine Global Corp. Announces Resignation of Mr. Doron Birger from the Board	Feb. 23	CI
Citrine Global Corp. announced that it has received $0.055 million in funding	Feb. 08	CI
Citrine Global Corp. acquired 19% stake in iBOT Israel-Botanicals LTD.	Dec. 30	CI
Citrine Global Corp. signed a binding agreement to acquire 19% stake in iBOT Israel-Botanicals LTD for NIS 5.23 million.	Nov. 20	CI
Citrine Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
Citrine Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-17	CI
Citrine Global Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Citrine Global Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI
Citrine Global Corp. acquired 18.33% of stake in Total Access Communication Public Company Limited from Thai Telco Holdings Limited.	23-02-14	CI
Citrine Global Corp. Announces Management Changes	23-01-18	CI
Citrine Global Corp. completed the acquisition of 10% stake in MyPlant Bio Ltd from PurPlant Inc and Cannasoul Analytics Ltd.	22-12-29	CI
Citrine Global Corp. entered into a Memorandum of Understanding to acquire 10% stake in MyPlant Bio Ltd from PurPlant Inc and Cannasoul Analytics Ltd for $0.44 million.	22-12-11	CI
Citrine Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-15	CI
Citrine Global Corp. Announces Executive Changes	22-10-25	CI
Citrine Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Citrine Global Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Citrine Global Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-08	CI
Citrine Global Corp. and Intelicanna Ltd Enters into Binding Memorandum of Understanding	22-01-20	CI
Citrine Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Citrine Global Subsidiary Files in the U.S. Patent & Trademark Office A Provisional Patent Application for Pharmaceutical Compositions and Methods for the Treatment of Side Effects Associated with the Use of Cannabis & Related Products	21-11-02	CI
Citrine Global Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Citrine Global Subsidiary Enters into Manufacturing Agreement for the Green Botanicals Product Line	21-08-10	CI
Citrine Global Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI
Citrine Global Corp. Appoints David Kretzmer as Member of the Board of Directors	21-04-30	CI
Citrine Global Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-15	CI

Chart Citrine Global Corp.

Duration

Period

More charts

Company Profile

Citrine Global Corp, formerly knows as Techcare Corp., is an Israeli-based company. The Company is engaged is an operational, asset and real estate finance, and consultancy in value creation and implementation strategy for technology companies. Citrine Global focuses on these industries such as health, wellness, food tech and medical cannabis.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
CITRINE GLOBAL CORP.	-37.50%	13.05M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution